Sunday, September 21, 2014

Best Income Companies To Invest In Right Now

Shares of food manufacturer The J.M. Smucker Company (SJM) reached a new 52-week high of $106.00 on Jul 11 following its fourth quarter fiscal 2013 results. The share price has been on the rise since the fourth quarter results on Jun 6, gaining 7.7% in just one month.

The stock closed at $105.93 on Jul 11, recording a healthy return of 19.4% on a year-to-date basis. The company�� long-term estimated EPS growth rate is 8.28%. Average volume of shares traded over the last three months came in at approximately 586K.

Solid Fourth Quarter

Smucker reported better-than-expected fourth quarter fiscal 2013 adjusted earnings of $1.29 per share. The results exceeded the Zacks Consensus Estimate by 12.2% and the prior-year adjusted earnings by 17% on the back of higher operating income, lower taxes and lower share count due to share buybacks.

Though revenues declined due to a decrease in net price realization, the company achieved volume gains in the U.S. Retail Coffee and U.S. Retail Consumer Foods segments, driven by higher priced K-Cups coffee and Dunkin Donut brands.

Top Transportation Companies To Invest In 2015: Hanmi Financial Corporation(HAFC)

Hanmi Financial Corporation operates as the holding company for Hanmi Bank that provides general business banking products and services in the United States. Its deposit product line comprises business and personal checking accounts, savings accounts, negotiable order of withdrawal accounts, money market accounts, and certificates of deposit. The company?s loan portfolio includes real estate loans, such as commercial property, construction, and residential property loans; commercial and industrial loans comprising commercial term loans, commercial lines of credit, small business administration loans, and international trade finance; and consumer loans consisting of automobile loans, secured and unsecured personal loans, home improvement loans, home equity lines of credit, overdraft protection loans, and unsecured lines of credit and credit cards. It also offers various insurance products, such as life, commercial, automobile, health, and property and casualty. The company serves the Korean-American community, as well as other communities in the multi-ethnic populations of Los Angeles County, Orange County, San Bernardino County, San Diego County, the San Francisco Bay area, and the Silicon Valley area in Santa Clara County. As of December 31, 2010, it operates a branch network of 27 full-service branch offices in California and one loan production office in Washington. Hanmi Financial Corporation was founded in 1981 and is headquartered in Los Angeles, California.

Advisors' Opinion:
  • [By GuruFocus]

    Hanmi Financial Corporation (HAFC): President and CEO Chong Guk Kum Bought 1,821 Shares

    President and CEO of Hanmi Financial Corporation (HAFC) Chong Guk Kum bought 1,821 shares on 09/20/2013 at an average price of $16.27. Hanmi Financial Corporation has a market cap of $513.615 million; its shares were traded at around $16.27 with a P/E ratio of 10.95 and P/S ratio of 3.82. The dividend yield of Hanmi Financial Corporation stocks is 0.43%.

Best Income Companies To Invest In Right Now: Cadence Pharmaceuticals Inc.(CADX)

Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting in the United States and Canada. It holds rights to OFIRMEV injection, a proprietary intravenous formulation of acetaminophen for the management of pain and reduction of fever in adults and children. The company in-licenses rights to OFIRMEV from Bristol-Myers Squibb Company, which sells intravenous acetaminophen in Europe and other markets for the treatment of acute pain and fever under the Perfalgan brand name. Cadence Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Equities Trading UP
    Cadence Pharmaceuticals (NASDAQ: CADX) shot up 26.42 percent to $14.02 after Mallinckrodt plc (NYSE: MNK) announced its plans to acquire Cadence Pharma for $14.00 per share in cash.

Best Income Companies To Invest In Right Now: Wilshire Bancorp Inc.(WIBC)

Wilshire Bancorp, Inc. operates as the holding company for Wilshire State Bank that offers a range of financial products and services. It accepts various deposit products that include certificates of deposit, regular savings accounts, money market accounts, checking and negotiable order of withdrawal accounts, installment savings accounts, and individual retirement accounts. The company?s loan portfolio comprises commercial real estate and home mortgage loans, commercial business lending and trade finance, and small business administration lending, as well as consumer loans, including personal loans, auto loans, and other loans. It also provides trade finance services that include issuance and negotiation of letters of credit, handling of documentary collections, advising and negotiation of commercial letters of credit, transfer and issuance of back-to-back letters of credit, and trade finance lines of credit. In addition, the company offers Internet banking services, auto matic teller machines, and armored carrier services. It has 24 full-service branch offices in Southern California, Texas, New Jersey, and the greater New York City metropolitan area; and 6 loan production offices in Colorado, Georgia, Texas, New Jersey, and Virginia. The company was founded in 1980 and is headquartered in Los Angeles, California.

Advisors' Opinion:
  • [By Rich Smith]

    Los Angeles-based Wilshire Bancorp (NASDAQ: WIBC  ) is acquiring some Korean banking customers... in New Jersey.

    On Monday, Wilshire announced that it has signed a definitive agreement to acquire�New Jersey's BankAsiana, a commercial bank�with three branches serving the Korean-American community in the New York/New Jersey market, boasting total assets of $207.3 million, total net loans of $161.2 million, and total deposits of $164.6 million.

  • [By Marc Bastow]

    Los-Angeles, California-based bank holding company Wilshire Bancorp (WIBC) raised its quarterly dividend 67% to 5 cents per share, payable April 15 to shareholders of record as of March 31.
    WIBC Dividend Yield: 1.77%

Best Income Companies To Invest In Right Now: Giant Interactive Group Inc (GA)

Giant Interactive Group Inc. (Giant Interactive), incorporated on July 26, 2006, is an online game developer and operator in China. The Company focuses on massively multiplayer online role playing games (MMORPG) that are played through networked game servers, in which a number of players are able to simultaneously connect and interact. The Company operates 11 online games, among which nine are self-developed, including the five games in the Zheng Tu (ZT) Online Series. As of December 31, 2010, its game development team consisted of 934 members, which includes product development and enhancement teams for each of its MMORPG and multiplayer online (MMO) games.

In January 2010, the Company acquired China operation licenses for Elsword and Allods Online, two three dimensional (3D) MMORPGs. In November 2010, the Company acquired Julun Network. On December 6, 2010, Zhengtu Information, Giant Network and Shanghai Juyan Network Technology jointly established Beijing Huayi Juren Information Technology Co., Ltd with 51%, 34% and 15% interest, respectively. On December 31, 2010, Zhengtu Information sold its 51% interest in Huayi Juren Information to Huayi Brothers Media Corporation. In May 2010, the Company acquired Snow Wolf.

The Company has built nationwide distribution and marketing networks to sell and market its prepaid game cards and game points. As of December 31, 2010, its distribution network consisted of more than 130 non-exclusive regional distributors and reached over 96,000 retail outlets, including Internet cafes, software stores, supermarkets, bookstores, newspaper stands and convenience stores located throughout China. The Company also sells game points through its official game Website. The Company generates its revenues from licensing of its games to third party operators in other territories, including Hong Kong, Macau, Taiwan, Malaysia, Singapore, Vietnam, Russia and other Russian speaking territories. In addition, it has also licensed its ZT Online Green Edition to! Shenzhen Tencent Computer Systems Company Limited (Tencent), on a non-exclusive basis for operation of such game on Tencent�� QQ game platform in China.

ZT Online

ZT Online is a two-dimensional, online role-playing game set in ancient China, and was the first game that was wholly developed by its internal product development team. ZT Online players assume one of five different roles, including soldiers and magicians, in 10 different kingdoms. In order to play ZT Online, players must log into one of multiple shards, or independent copies of the game world. Players can only interact with other players in his or her respective shard at any given time, and its technology enables players to travel among the different shards. The Company has developed technology for use in ZT Online that allows up to 40,000 players to play together in a single shard at any given time. ZT Online is free of charge to play. Players may purchase physical or virtual prepaid game cards and game points on its game Website or from Internet cafes and other distribution points, which allow their characters to obtain gold coins, one of the currencies used in the ZT Online game. Players may also earn silver coins for their characters when they fulfill tasks or adventures in the game world.

The game has gold coin vouchers, which are offered both as a salary to players who meet certain requirements and as a reward in connection with certain of its promotions. Players may trade silver coins for gold coins, and vice-versa, inside the game. Neither gold coins, gold coin vouchers, nor silver coins may be used by players to purchase any items or services outside of the ZT Online game. ZT Online allows players to purchase a range of virtual items and services for their characters using their gold and/or silver coins. These include weapons, clothing, pets, ceremonies and rites, and others. Weapons may be repaired or replaced by purchases of certain in-game raw materials or by payment of additional gold or! silver c! oins. ZT Online offers a play experience, where players can choose to enter the game 24 hours a day, seven days a week. ZT Online can be accessed from any location with an Internet connection. It has licensed ZT Online to Lager Network for operation in Hong Kong, Macau, Taiwan, Malaysia and Singapore, licensed ZT Online to VinaGame for operation in Vietnam, and licensed ZT Online to Atrum Nival for operation in the Russia and other Russian speaking territories.

ZT Online PTP

ZT Online PTP is pay-to-play MMORPG game developed by the Company, and is based on the ZT Online free-to-play game. As in ZT Online, players assume one of five different roles in 10 different kingdoms. ZT Online PTP also requires players to log into one of multiple shards, while enabling players to travel between different shards. ZT Online PTP requires players to pay to play the game by purchasing physical or virtual prepaid game cards on its game Website or from Internet cafes and other distribution points. ZT Online PTP shares the same graphics and system requirements as ZT Online.

Giant Online

Giant Online is a military-themed MMORPG. Giant Online players may assume one of 14 different roles, such as detectives and spies. As with ZT Online, the game world in Giant Online is divided into a number of regions. Each player must guide his or her character to develop skills and cooperate with other players to fight against players from other regions. Players can equip their characters with a range of modern weaponry. Apart from waging war, characters can also engage in forms of in-game social interaction, such as friendship and even romance. Giant Online enables players, and groups of players, to purchase a range of virtual items and services. These virtual items and services include weapons, vehicles and pets. Giant Online is a 2.5 dimensional game, the background and items in the game are depicted three dimensionally, while the characters are depicted two dimensionally.

King of! Kings III

K III is a three-dimensional online role-playing experience set in a European-style magical world. Players assume the roles of K III heroes as they explore across a virtual world of forests and medieval cities and castles. K III is the third episode of the King of Kings series of MMORPGs.

My Sweetie

My Sweetie is a 2.5D free-to-play casual MMO game, which allows players to create virtual characters, raise virtual pets on their personal computer desktops and go online to interact with other virtual pet-owners. My Sweetie is the game developed pursuant to its Win@Giant program.

XT Online is a 2.5D ancient Chinese martial arts MMORPG that was developed by Snow Wolf, a game development studio. XT Online enables users to practice different schools or styles of martial arts with the goal of becoming a master, while focusing on brotherhood and trust-building with other martial artists. The Golden Land is a free-to-play medieval strategy browser game, which was developed by Juhe Network, one of its 51% owned game development studios. ZT Online II is an internally-developed free-to-play 2D sequel to its game ZT Online. ZT Online II was developed by an internal studio that it is reorganizing into Jujia Network, one of its 51% owned game development studios.

Dragon Soul is an internally developed 3D ancient Chinese MMORPG developed by Chengdu Jufan Network Technology Co. Ltd. (Jufan Network) one of its 51% owned game development studios. Spirits of the Warriors is a free-to-play 3D MMORPG based on the Three Kingdoms period of ancient Chinese history.

Advisors' Opinion:
  • [By Lauren Pollock]

    Giant Interactive Group Inc.(GA) named three of its directors to a special committee intended to review a nonbinding proposal to take the online-game company private. Last week, investors including former chief executive Chairman Yuzhu Shi and Baring Private Equity Asia offered to acquire the stake they don’t already own for $11.75 a share.

  • [By Jake L'Ecuyer]

    Equities Trading UP
    Giant Interactive Group (NYSE: GA) shot up 11.97 percent to $11.34 after the company received a non-binding proposal to acquire the company for $11.75 per share.

  • [By Kevin Chen]

    Two companies that seem on an unstoppable path of profits are Giant Interactive� (NYSE: GA  ) and NetEase (NASDAQ: NTES  ) .�Meanwhile, Shanda Games� (NASDAQ: GAME  ) and Perfect World� (NASDAQ: PWRD  ) haven't done as well.

  • [By Eric Volkman]

    Giant Interactive Group (NYSE: GA  ) has quickly replaced its chief executive. One week after announcing the resignation of Yuzhu Su, the company revealed that its board has tapped Wei Liu as its new CEO.

Best Income Companies To Invest In Right Now: Idera Pharmaceuticals Inc.(IDRA)

Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks activation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for hepatitis C virus infection; and TLR7, 8, and 9 agonists that are in research stage for viral diseases. The company also develops IMO-3100, a dual TLR7/TLR9 antagonist, which is in preclinical development stage for autoimmune and inflammatory diseases, such as lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis. In addition, its drug candidates also comprise TLR7 and TLR8 agonists that are in research stage for solid tumor cancers. The company has a licensing and collaboration agreement with Merck KGaA to research, develop, and commercialize TLR9 agonists for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize therapeutic and prophylactic vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimer?s disease; and a research collaboration and option agreement, and a license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. The company was founded in 1989 and is based in Cambridge, Massachusetts.

Advisors' Opinion:
  • [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

    Idera Pharmaceuticals Inc.(IDRA) said a recent clinical study of its plaque psoriasis treatment met its objectives, allowing the company to push forward with the treatment’s development. The company’s shares jumped 32% to $5.14 premarket.

Best Income Companies To Invest In Right Now: United States Natural Gas Fund LP (UNG)

United States Natural Gas Fund, LP (USNG) is a limited partnership. The Company is a commodity pool that issues limited partnership interests (units) traded on the NYSE Arca, Inc. (the NYSE Arca). The investment objective of USNG is for the changes in percentage terms of its units��net asset value (NAV) to reflect the changes in percentage terms of the spot price of natural gas delivered at the Henry Hub, Louisiana as measured by the changes in the Futures Contract on natural gas traded on the New York Mercantile Exchange (NYMEX) that is the near month contract to expire, except when the near month contract is within two weeks of expiration, in which case the futures contract will be the next month contract to expire. The Company�� general partner is United States Commodity Funds LLC (the General Partner) and is responsible for the management of USNG.

USNG invests in futures contracts for natural gas, crude oil, heating oil, gasoline, and other petroleum-based fuels that are traded on the NYMEX, ICE Futures or other United States and foreign exchanges (collectively, Futures Contracts). USNG also invests in other natural gas-related investments, such as cash-settled options on Futures Contracts, forward contracts for natural gas, cleared swap contracts, and over-the-counter transactions that are based on the price of natural gas, oil and other petroleum-based fuels, Futures Contracts and indices based on the foregoing (collectively, Other Natural Gas-Related Investments). USNG invests in Natural Gas Interests to the fullest extent possible. In pursuing this objective, the primary focus of the General Partner is the investment in Futures Contracts and the management of USNG�� investments in short-term obligations of the United States of two years or less (Treasuries), cash and/or cash equivalents for margining purposes and as collateral.

Advisors' Opinion:
  • [By Paul Ausick]

    The US Natural Gas Fund (NYSEMKT: UNG) is up 2.4%, at $19.14 in a 52-week range of $16.59 to $24.09. The Market Vectors Oil Services ETF (NYSEMKT: OIH) is down 0.6%, at $47.37 in a 52-week range of $36.24 to $47.76. The first fund tracks spot prices; the second includes major drillers and services companies.

  • [By Paul Ausick]

    The U.S. Natural Gas Fund (NYSEMKT: UNG) is down 1.4%, at $19.03 in a 52-week range of $16.59 to $24.09. The Market Vectors Oil Services ETF (NYSEMKT: OIH) is up 1.2%, at $46.34 in a 52-week range of $36.24 to $46.78. The first fund tracks spot prices; the second includes major drillers and services companies.

Best Income Companies To Invest In Right Now: Cubist Pharmaceuticals Inc.(CBST)

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), a once-daily, bactericidal, intravenous, antibiotic with activity against gram-positive organisms, including methicillin-resistant staphylococcus aureus. Its clinical development product pipeline consists of CXA-201, which is in the phase III clinical trial for patients with complicated urinary tract infections; and in phase II clinical trial for patients with complicated abdominal infections. The company is also developing CXA-201 for the treatment of hospital acquired pneumonia. In addition, its product under development comprises CB-183,315, an oral, bactericidal lipopeptide with in vitro bactericidal activity against C. difficile, for the treatment of clostridium difficile-associated diarrhea (CDAD). Further , the company?s pre-clinical programs include therapies to treat various bacterial infections and agents to treat acute pain. Additionally, it promotes MERREM I.V. (meropenem for injection), a carbapenem class intravenous antibiotic, in the United States under a commercial services agreement with AstraZeneca Pharmaceuticals, LP; and DIFICID as the treatment for CDAD in adults under the co-promotion agreement with Optimer Pharmaceuticals, Inc. The company also has collaborations with Forma Therapeutics, Inc. to discover and develop antibacterial compounds; an agreement with the Broad Institute to transform natural products discovery; a collaboration with Hydra Biosciences, Inc., to develop ion channel drugs; and a collaboration agreement with Alnylam Pharmaceuticals, Inc., for the development and commercialization of Alnylam's RNAi therapeutics as a therapy for the treatment of respiratory syncytial virus. The company was founded in 1992 and is headquartered in Lexington, Mas sachusetts.

Advisors' Opinion:
  • [By Jon C. Ogg]

    Cubist Pharmaceuticals Inc. (NASDAQ: CBST) was raised to Outperform from Market Perform at Leerink Swann.

    Diamondback Energy Inc. (NASDAQ: FANG) was downgraded to Hold from Buy at Canaccord Genuity.

  • [By Rich Bieglmeier]

    [Related -Cubist Pharmaceuticals Inc. (CBST): All-Time Highs On The Horizon?]

    The FDA has accepted the Company's New Drug Application (NDA) for its investigational antibiotic tedizolid phosphate (TR-701) with Priority Review. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of June 20, 2014. Cubist is seeking FDA approval of tedizolid for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

No comments:

Post a Comment